Indiana 2024 Regular Session

Indiana House Bill HB1188 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1
2	2	Introduced Version
3	3	HOUSE BILL No. 1188
4	4	_____
5	5	DIGEST OF INTRODUCED BILL
6	6	Citations Affected: IC 12-15-5-13.
7	7	Synopsis: Mental health and addiction services. Prohibits lifetime
8	8	limitations on a Medicaid recipient receiving substance use disorder
9	9	inpatient rehabilitation or treatment.
10	10	Effective: July 1, 2024.
11	11	Pack
12	12	January 9, 2024, read first time and referred to Committee on Public Health.
13	13	2024 IN 1188—LS 6632/DI 104 Introduced
14	14	Second Regular Session of the 123rd General Assembly (2024)
15	15	PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
16	16	Constitution) is being amended, the text of the existing provision will appear in this style type,
17	17	additions will appear in this style type, and deletions will appear in this style type.
18	18	Additions: Whenever a new statutory provision is being enacted (or a new constitutional
19	19	provision adopted), the text of the new provision will appear in this style type. Also, the
20	20	word NEW will appear in that style type in the introductory clause of each SECTION that adds
21	21	a new provision to the Indiana Code or the Indiana Constitution.
22	22	Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
23	23	between statutes enacted by the 2023 Regular Session of the General Assembly.
24	24	HOUSE BILL No. 1188
25	25	A BILL FOR AN ACT to amend the Indiana Code concerning
26	26	human services.
27	27	Be it enacted by the General Assembly of the State of Indiana:
28	28	1 SECTION 1. IC 12-15-5-13, AS AMENDED BY P.L.179-2019,
29	29	2 SECTION 1, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
30	30	3 JULY 1, 2024]: Sec. 13. (a) The office shall provide coverage for
31	31	4 treatment of opioid or alcohol dependence that includes the following:
32	32	5 (1) Counseling services that address the psychological and
33	33	6 behavioral aspects of addiction.
34	34	7 (2) When medically indicated, drug treatment involving agents
35	35	8 approved by the federal Food and Drug Administration for the:
36	36	9 (A) treatment of opioid or alcohol dependence; or
37	37	10 (B) prevention of relapse to opioids or alcohol after
38	38	11 detoxification.
39	39	12 (3) When determined by the treatment plan to be medically
40	40	13 necessary, inpatient detoxification in accordance with the most
41	41	14 current edition of the American Society of Addiction Medicine
42	42	15 Patient Placement Criteria.
43	43	16 (b) The office shall:
44	44	17 (1) develop quality measures to ensure; and
45	45	2024 IN 1188—LS 6632/DI 104 2
46	46	1 (2) require a managed care organization to report;
47	47	2 compliance with the coverage required under subsection (a).
48	48	3 (c) The office may implement quality capitation withholding of
49	49	4 reimbursement to ensure that a managed care organization has
50	50	5 provided the coverage required under subsection (a).
51	51	6 (d) The office shall report the clinical use of the medications
52	52	7 covered under this section to the mental health Medicaid quality
53	53	8 advisory committee established by IC 12-15-35-51. The mental health
54	54	9 Medicaid quality advisory committee may make recommendations to
55	55	10 the office concerning this section.
56	56	11 (e) The office may not place an overall limitation on the amount
57	57	12 of substance use disorder inpatient rehabilitation or treatment that
58	58	13 a Medicaid recipient may receive in the recipient's lifetime.
59	59	2024 IN 1188—LS 6632/DI 104